Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vorinostat and Radiation Therapy in Locally Advanced Pancreatic Cancer
NCT00831493Phase 2Terminated
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- May 2009
- Primary completion
- Oct 2010
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vorinostat in pancreatic cancer (PC), sponsored by University of Texas MD Anderson Cancer Center. Started May 2009; status: terminated.
02
Drugs
vorinostat
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00831493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00831493.